Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4465 - 4472 of 11613 results
Thinking like an entrepreneur: Cheryl Reicin
September 27, 2019| News
The Long-Awaited Final Overtime Rule Has Landed
September 26, 2019| Blog| Viewpoint
To Pitch Pre-Cert to Congress, FDA Builds a Case First
September 26, 2019| News
Uniform Commercial Code Financing Statement is Integral in Bond Defaults
September 26, 2019| News
Federal Judge Rules FBI Agents Conducted Illegal Search of Business
September 26, 2019| News
US Judge Faults Warrant, Orders Suppression of Seized Business Records
September 26, 2019| News
Risks of Imperfect Perfection, and How to Avoid Them
September 25, 2019| Blog| Viewpoint
The Risks of Imperfect Perfection, and How to Avoid Them
September 25, 2019| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.